Log in

2335 Shaanxi Micot Pharmaceutical Technology Co., Ltd. HKEX · China

Shaanxi Micot Pharmaceutical Technology Co. (2335) news

Shaanxi Micot Pharmaceutical Technology Co., Ltd. is a public biotech or pharmaceutical company listed on HKEX under the ticker 2335, recorded under China. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Shaanxi Micot Pharmaceutical Technology Co. news

We have not published a story on Shaanxi Micot Pharmaceutical Technology Co. yet. When there is news, it will appear here.

Questions about Shaanxi Micot Pharmaceutical Technology Co.

What is the ticker symbol of Shaanxi Micot Pharmaceutical Technology Co.?

Shaanxi Micot Pharmaceutical Technology Co., Ltd. trades under the ticker 2335 on HKEX.

Where is Shaanxi Micot Pharmaceutical Technology Co. listed?

Shaanxi Micot Pharmaceutical Technology Co., Ltd. is listed on HKEX.

Which country or territory is Shaanxi Micot Pharmaceutical Technology Co. listed under?

Our directory records Shaanxi Micot Pharmaceutical Technology Co., Ltd. under China.

What does Shaanxi Micot Pharmaceutical Technology Co. do?

Our directory classifies Shaanxi Micot Pharmaceutical Technology Co., Ltd. as: Biotechnology. This is a directory classification, not a description of the pipeline.

What is the ISIN of Shaanxi Micot Pharmaceutical Technology Co.?

The ISIN recorded for Shaanxi Micot Pharmaceutical Technology Co., Ltd. is CNE100007Q79.

Does aibio.space cover Shaanxi Micot Pharmaceutical Technology Co.?

aibio.space lists Shaanxi Micot Pharmaceutical Technology Co., Ltd. among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Shaanxi Micot Pharmaceutical Technology Co.?

Companies in our directory listed in the same country and business area as Shaanxi Micot Pharmaceutical Technology Co.: HJ Science Co., Qingdao Vland Biotech INC., Hubei Goto Biopharm Group Co., Beijing Tiantan Biological Products Corporation, Innovita Biological Technology Co., Sunshine Lake Pharma Co..

Investor discussion: Shaanxi Micot Pharmaceutical Technology Co.

Members talk about Shaanxi Micot Pharmaceutical Technology Co. (2335). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Capital-markets timeline

Financings, listing notices, splits, legal actions and other investor events at Shaanxi Micot Pharmaceutical Technology Co., newest first. Each line links the filing it comes from.

  1. Financings

    Share or debt issue: PROPOSED GENERAL MANDATE TO REPURCHASE H SHARES AND NOTICE OF EXTRAORDINARY GENERAL MEETING. Source

  2. Financings

    Share or debt issue: GLOBAL OFFERING. Source

Press releases

Headlines of Shaanxi Micot Pharmaceutical Technology Co.'s own announcements, newest first. Each opens the full release on the newswire that carried it.

  1. HKEXnews

    NOTICE OF EXTRAORDINARY GENERAL MEETING

  2. HKEXnews

    PROPOSED GENERAL MANDATE TO REPURCHASE H SHARES AND NOTICE OF EXTRAORDINARY GENERAL MEETING

  3. HKEXnews

    PROPOSED ADOPTION OF THE H SHARE INCENTIVE SCHEME AND PROPOSED GENERAL MANDATE TO REPURCHASE H SHARES

  4. HKEXnews

    NOTIFICATION LETTER TO NON-REGISTERED SHAREHOLDERS AND REPLY FORM

  5. HKEXnews

    VOLUNTARY ANNOUNCEMENT - INCLUSION IN THE STOCK LIST UNDER THE STOCK CONNECT PROGRAM (SHANGHAI-HONG KONG STOCK CONNECT AND SHENZHEN-HONG KONG STOCK CONNECT)

  6. HKEXnews

    INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2026

  7. HKEXnews

    VOLUNTARY ANNOUNCEMENT - COMPLETION OF PHASE II CLINICAL TRIAL OF MT200605 FOR ACUTE ISCHEMIC STROKE (AIS) IN CHINA

  8. HKEXnews

    VOLUNTARY ANNOUNCEMENT - INCLUSION OF THE COMPANY AS A CONSTITUENT STOCK OF HANG SENG COMPOSITE INDEX

  9. HKEXnews

    VOLUNTARY ANNOUNCEMENT XTL6001 RESEARCH ACCEPTED FOR PRESENTATIONS AT EASD 2026 AND ASN KIDNEY WEEK 2026

  10. HKEXnews

    VOLUNTARY ANNOUNCEMENT PRECLINICAL AND PHASE I CLINICAL DATA OF MT200605 ACCEPTED FOR ORAL PRESENTATION AT THE 18TH WORLD STROKE CONGRESS 2026

  11. HKEXnews

    VOLUNTARY ANNOUNCEMENT PHASE II CLINICAL TRIAL OF MT200605 FOR ACUTE ISCHEMIC STROKE (AIS) REACHED PRIMARY ENDPOINT

  12. HKEXnews

    VOLUNTARY ANNOUNCEMENT - PHASE II CLINICAL TRIAL OF MT200605 FOR ACUTE ISCHEMIC STROKE (AIS) COMPLETED DATABASE LOCK

  13. HKEXnews

    VOLUNTARY ANNOUNCEMENT - FIRST PATIENT ENROLLED IN PHASE II CLINICAL TRIAL OF MT1002 FOR ANTICOAGULATION IN HEMODIALYSIS (HD) PATIENTS

  14. HKEXnews

    VOLUNTARY ANNOUNCEMENT - FIRST PATIENT ENROLLED IN THE PHASE IB/II CLINICAL TRIAL OF MT1002 FOR ACUTE ISCHEMIC STROKE

  15. HKEXnews

    ANNOUNCEMENT OF ALLOTMENT RESULTS

  16. HKEXnews

    TERMS OF REFERENCE OF THE REMUNERATION COMMITTEE

  17. HKEXnews

    TERMS OF REFERENCE OF THE NOMINATION COMMITTEE

  18. HKEXnews

    TERMS OF REFERENCE OF THE AUDIT COMMITTEE

  19. HKEXnews

    Articles of Association

  20. HKEXnews

    Documents on Display

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open HKEX:2335 on TradingView.

Listing details

Shaanxi Micot Pharmaceutical Technology Co., Ltd. is a public biotech or pharmaceutical company listed on HKEX under the ticker 2335, recorded under China. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Shaanxi Micot Pharmaceutical Technology Co., Ltd.
Ticker
2335
Listing
HKEX
Country or territory
China
Business scope
Biotechnology
ISIN
CNE100007Q79
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

aibio.space

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.